SCHEMBL8855640

SCHEMBL8855640

CC(C)(CBr)NCC(O)Cn1ccnc1[N+](=O)[O-]

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.57
LMNA P02545 1/20 0.44
THRB P10828 1/20 0.44
CYP2C19 P33261 1/20 0.44
CA12 O43570 5/20 0.42
CA1 P00915 5/20 0.42
CA2 P00918 5/20 0.42
CA9 Q16790 5/20 0.42
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
OPRK1 P41145 1/20 0.38
TYMP P19971 3/20 0.37
L3MBTL1 Q9Y468 1/20 0.32
ADRB2 P07550 1/20 0.32
ADRB1 P08588 1/20 0.32
ADRB3 P13945 1/20 0.32
NOS1 P29475 1/20 0.31
CCR10 P46092 2/20 0.30
CHRM1 P11229 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL8855602 0.99 KMT2A (0.56) KMT2ALMNATHRBCYP2C19CA12
SCHEMBL9085256 0.89 KMT2A (0.58) KMT2ALMNATHRBCYP2C19CA12
SCHEMBL8855592 0.88 KMT2A (0.57) KMT2ALMNATHRBCYP2C19CA12
SCHEMBL11348169 0.88 KMT2A (0.62) KMT2ALMNATHRBCYP2C19CA12
Hydrochloric Acid SCHEMBL8855469 0.87 KMT2A (0.56) KMT2ALMNATHRBCYP2C19CA12
SCHEMBL8855479 0.87 KMT2A (0.58) KMT2ALMNATHRBCYP2C19CA12
Hydrochloric Acid SCHEMBL11455609 0.87 KMT2A (0.60) KMT2ALMNATHRBCYP2C19CA12
Bromide SCHEMBL8855683 0.86 KMT2A (0.57) KMT2ALMNATHRBCYP2C19CA12
SCHEMBL8855648 0.84 KMT2A (0.57) KMT2ALMNATHRBCYP2C19CA12
Hydrochloric Acid SCHEMBL8855620 0.83 KMT2A (0.56) KMT2ALMNATHRBCYP2C19CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5652255-A ADMINISTERING NITROIMIDAZOLE DERIVATIVE NITRIC OXIDE SYNTHASE INHIBITOR; ANTITUMOR AGENTS BRITISH TECHNOLOGY GROUP LIMITED (GB) 1997-07-29 US claimed
EP-0319329-B1 Nitro-substituted aromatic or hetero-aromatic compounds for use in cancer treatment BRITISH TECH GROUP (GB) 1995-11-02 EP claimed
US-5652255-A ADMINISTERING NITROIMIDAZOLE DERIVATIVE NITRIC OXIDE SYNTHASE INHIBITOR; ANTITUMOR AGENTS BRITISH TECHNOLOGY GROUP LIMITED (GB) 1997-07-29 US disclosed
US-5521203-A INCREASES SENSITIVITY OF CELLS TO RADIATION AND CHEMOTHERAPY BRITISH TECHNOLOGY GROUP LIMITED (GB) 1996-05-28 US disclosed
EP-0319329-B1 Nitro-substituted aromatic or hetero-aromatic compounds for use in cancer treatment BRITISH TECH GROUP (GB) 1995-11-02 EP disclosed
US-5098921-A Antitumor agents NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1992-03-24 US disclosed
EP-0319329-A2 Nitro-substituted aromatic or hetero-aromatic compounds for use in cancer treatment BTG INTERNATIONAL LIMITED (GB) 1989-06-07 EP disclosed